Skip to content
Menu

Silence Therapeutics Q3 EPS $(0.24) Misses $(0.12) Estimate

Benzinga Newsdesk 1 week ago

NewsEarningsEarnings Misses

This page contains a summary, not the full article. Continue to benzinga.com to read the original report.

Silence Therapeutics (NASDAQ:SLN) reported quarterly losses of $(0.24) per share which missed the analyst consensus estimate of $(0.12) by 100 percent. This is a 46.67 percent increase over losses of $(0.45) per share

Silence Therapeutics (NASDAQ:SLN) reported quarterly losses of $(0.24) per share which missed the analyst consensus estimate of $(0.12) by 100 percent. This is a 46.67 percent increase over losses of $(0.45) per share from the same period last year.

Read at benzinga.com

← All stock news